1. Strauss LG, Conti PS. The applications of PET in clinical oncology.J Nucl Med 1991; 32: 623–648.
2. Kamel R, Schwarzfisher F. Hexokinase isozymes in human neoplastic and fetal tissues: the existence of hexokinase II in malignant tumors and in placenta.Humangenetik 1975; 30: 181–185.
3. Beemer FA, Vlug AM, Rijksen G, Hamburg A, Staal GE. Characterization of some glycolytic enzymes from human retina and retinoblastoma.Cancer Res 1982; 42: 4228–4232.
4. Balinsky D, Platz CE, Lewis JW. Isozyme patterns of normal, benign, and malignant human breast tissues.Cancer Res 1983; 43: 5895–5901.
5. Higashi T, Saga T, Nakamoto Y, et al. Relationship between retention index in dual-phase (18)F-FDG PET, and hexokinase-II and glucose transporter-1 expression in pancreatic cancer.J Nucl Med 2002; 43: 173–180.